Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
40.16 USD | +1.74% | -2.55% | +1.26% |
05:34pm | Celldex Therapeutics Reports First Patient Dosed in Phase 2 Skin Disorder Study | MT |
May. 06 | Earnings Flash (CLDX) CELLDEX THERAPEUTICS Posts Q1 Revenue $156,000 | MT |